Cited by 163Bipolar Disorder and TreatmentTryptophan and brain disordersTreatment of Major Depression

The DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.

TNF-α as a molecular target in bipolar disorder

Brietzke, Elisa, Kapczinski, Flávio·2008·Progress in Neuro-Psychopharmacology and Biological Psychiatry

DOI 10.1016/j.pnpbp.2008.01.006

Open this paper in CoChat — free account

Abstract

The pathophysiology of bipolar disorder (BD) is poorly understood. An emerging body of evidence points to impairments in neuroplasticity, cell resilience and neuronal survival as the main neuropathological correlates of BD. It has been suggested that inflammatory cytokines, particularly TNF-alpha may play a critical role in this process. In the present review we examine the evidence suggesting that TNF-alpha regulates apoptotic cascades which may be related to neuronal and glial loss in BD. Current evidence suggests that an increase in serum levels of TNF-alpha takes place during manic and depressive episodes. The present article reviews the therapeutic implications of TNF-alpha signaling pathways involvement in the pathophysiology of BD.

Integrity signals

Registry

Crossref · 10.1016/j.pnpbp.2008.01.006

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Mortality of patients with mood disorders: follow-up over 34–38 years
Angst, F., Stassen, H. H., Clayton, P. J., & Angst, J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00377-9 · Cited by 881
Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells
Rajkowska, G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00950-1 · Cited by 822
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784
Depressive disorders and immunity: 20 years of progress and discovery
Irwin, M. R., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.01.010 · Cited by 676
Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium
Uranova, N. A., Vostrikov, V. M., Orlovskaya, D. D., & Rachmanova, V. I. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00181-6 · Cited by 659
Functional outcome in bipolar disorder: the role of clinical and cognitive factors
Martínez‐Arán, A., Vieta, E., Torrent, C., Sánchez‐Moreno, J., Goikolea, J. M., Salamero, M., Malhi, G. S., González-Pinto, A. M., Daban, C., Alvarez-Grandi, S. A., et al. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00327.x · Cited by 615
Roles for NF-κB in nerve cell survival, plasticity, and disease
Mattson, M. P., & Meffert, M. K. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401837 · Cited by 612

Show all 58 references

Research works printed but not linked: 2

Balakumar, 2006, Anti-tumor necrosis factor-α in heart failure: future directions, Pharmacol Toxicol, 99, 391
Kim, 2003, Association Study of Tumor Necrosis Factor-Alpha Gene Polymorphism in schizophrenia and bipolar disorder, J Korean Neuropsychiatr Assoc, 42, 559

Sorted by citations

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Self-citation
Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2012) · Blood · doi:10.1182/blood-2011-04-325225 · Cited by 877
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder
Kauer‐Sant’Anna, M., Kapczinski, F. P., Andreazza, A. C., Bond, D. J., Lam, R. W. M., Young, L. T., & Yatham, L. N. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009310 · Cited by 442
Self-citation
Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients
Rao, J. S., Harry, G. J., Rapoport, S. I., & Kim, H. W. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.47 · Cited by 432
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423
Self-citation
Biomarkers and clinical staging in psychiatry
McGorry, P. D., Keshavan, M. S., Goldstone, S. D., Amminger, G. P., Allott, K., Berk, M., Lavoie, S., Pantelis, C., Yung, A. R., Wood, S. J., et al. (2014) · World Psychiatry · doi:10.1002/wps.20144 · Cited by 324
Stress and Inflammation Reduce Brain-Derived Neurotrophic Factor Expression in First-Episode Psychosis
Mondelli, V., Cattaneo, A., Murri, M. B., Forti, M. D., Handley, R., Hepgul, N., Miorelli, A., Navari, S., Papadopoulos, A. S., Aitchison, K. J., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06745 · Cited by 307
Neuroinflammation and cytokine abnormality in major depression: cause or consequence in that illness?
Jeon, S. W., & Kim, Y. K. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i3.283 · Cited by 247
Marine omega‐3 (n‐3) phospholipids: A comprehensive review of their properties, sources, bioavailability, and relation to brain health
Ahmmed, M. K., Ahmmed, F., Tian, H. S., Carne, A., & Bekhit, A. E. A. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12510 · Cited by 254
A role for white matter abnormalities in the pathophysiology of bipolar disorder
Mahon, K., Burdick, K. E., & Szeszko, P. R. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.10.012 · Cited by 231
Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
Fillman, S. G., Sinclair, D., Fung, S. J., Webster, M. J., & Shannon Weickert, C. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.8 · Cited by 226
Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance
Kunz, M., Ceresér, K. M. M., Goi, P. D., Fries, G. R., Teixeira, A. L., Fernandes, B. S., Belmonte-de-Abreu, P. S., Kauer‐Sant’Anna, M., Kapczinski, F. P., & Gama, C. S. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000300010 · Cited by 189
Self-citation
Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications
Scaini, G., Rezin, G. T., Carvalho, A. F., STRECK, E. L., Berk, M., & Quevedo, J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.040 · Cited by 187
Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications
Rosenblat, J. D., Brietzke, E., Mansur, R. B., Maruschak, N. A., Lee, Y., & McIntyre, R. S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.058 · Cited by 172
Self-citation
The potential use of biomarkers as an adjunctive tool for staging bipolar disorder
Kapczinski, F. P., Dias, V. V., Kauer‐Sant’Anna, M., Brietzke, E. M., Vázquez, G. H., Vieta, E., & Berk, M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.027 · Cited by 170
Self-citation
Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus
Soczynska, J. K., Kennedy, S. H., Woldeyohannes, H. O., Liauw, S. S. L., Alsuwaidan, M. T., Yim, C. Y., & McIntyre, R. S. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8140-8 · Cited by 167
Tumor necrosis factor alpha in sleep regulation
Rockstrom, M. D., Chen, L., Taishi, P., Nguyen, J., Gibbons, C. M., Veasey, S. C., & Krueger, J. M. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.10.005 · Cited by 166
Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor
Hope, S., Melle, I. S., Aukrust, P., Steen, N. E., Birkenaes, A. B., Lorentzen, S., Agartz, I., Ueland, T., & Andreassen, O. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00757.x · Cited by 155
Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
Brietzke, E. M., Kauer‐Sant’Anna, M., Teixeira, A. L., & Kapczinski, F. P. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.04.008 · Cited by 127
Self-citation
Staging Bipolar Disorder
Vieta, E., Reinares, M., & Rosa, A. R. (2011) · Neurotoxicity Research · doi:10.1007/s12640-010-9197-8 · Cited by 120
The role of neuroinflammation and neurovascular dysfunction in major depressive disorder
Jeon, S. W., & Kim, Y. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s141033 · Cited by 123
State-dependent microstructural white matter changes in bipolar I depression
Zanetti, M. V., Jackowski, M. P., Versace, A., Almeida, J., Hassel, S., Duran, F., Busatto, G. F., Kupfer, D. J., & Phillips, M. L. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0002-8 · Cited by 115
Staging and Neuroprogression in Bipolar Disorder: A Systematic Review of the Literature
Gama, C. S., Kunz, M., Magalhães, P. V. D. S., & Kapczinski, F. P. (2013) · Brazilian Journal of Psychiatry · doi:10.1016/j.rbp.2012.09.001 · Cited by 112
Self-citation
Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.
Barbosa, I. G., Huguet, R. B., Mendonça, V. A., Sousa, L. P., Neves, F. S., Bauer, M. E., & Teixeira, A. L. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0116-z · Cited by 108
Cytokine levels in euthymic bipolar patients
Guloksuz, S., Aktas Cetin, E., Cetin, T., Deniz, G., Oral, E. T., & Nutt, D. J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.027 · Cited by 102
Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application
Watkins, C. C., Sawa, A., & Pomper, M. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.119 · Cited by 100
Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia
Asevedo, E. D. M., Gadelha, A., Noto, C. D. S., Mansur, R. B., Zugman, A., Belangero, S. I., Berberian, A. D. A., Scarpato, B. S., Leclerc, E., Teixeira, A. L., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.032 · Cited by 101
Self-citation
From neuroprogression to neuroprotection: implications for clinical care.
Berk, M., Conus, P., Kapczinski, F. P., Andreazza, A. C., Yücel, M., Wood, S. J., Pantelis, C., Malhi, G. S., Dodd, S., Bechdolf, A., et al. (2010) · PubMed · Cited by 96
Self-citation
The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: Novel hypothesis-driven treatments for bipolar depression?
Soczynska, J. K., Kennedy, S. H., Goldstein, B. I., Lachowski, A. M., Woldeyohannes, H. O., & McIntyre, R. S. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.03.004 · Cited by 96
Telomere Length, Oxidative Stress, Inflammation and BDNF Levels in Siblings of Patients with Bipolar Disorder: Implications for Accelerated Cellular Aging
Vasconcelos-Moreno, M. P., Fries, G. R., Gubert, C., dos Santos, B. T. M. Q., Fijtman, A., Sartori, J., Ferrari, P., Grün, L. K., Parisi, M. M., Guma, F. T. C. R., et al. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx001 · Cited by 95
Self-citation
Increased soluble tumor necrosis factor‐α receptors in patients with major depressive disorder
Grassi‐Oliveira, R., Brietzke, E., Pezzi, J. C., Lopes, R. P., Teixeira, A. L., & Bauer, M. E. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01918.x · Cited by 92
Self-citation
Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application
Rege, S., & Hodgkinson, S. J. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413499077 · Cited by 90
Levels of TNF‐α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder
Baysal, Ö. D., Ci̇nemre, B., Aksoy, U. M., Akbas, H. S., Metin, Ö., Fettahoğlu, E. Ç., Gökmen, Z., & Davran, F. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2301 · Cited by 84
Altered serum levels of TNF-α, IL-6 and IL-18 in manic, depressive, mixed state of bipolar disorder patients
Luo, Y., He, H., Zhang, M., Huang, X., & Fan, N. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.07.027 · Cited by 83
Staging Models in Bipolar Disorder: A Systematic Review of the Literature
Muneer, A. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.2.117 · Cited by 76
The Immune Profile of Major Dysmood Disorder: Proof of Concept and Mechanism Using the Precision Nomothetic Psychiatry Approach
Maes, M. H. J., Rachayon, M., Jirakran, K., Sodsai, P., Klinchanhom, S., Gałecki, P., Sughondhabirom, A., & Basta‐Kaim, A. (2022) · Cells · doi:10.3390/cells11071183 · Cited by 69
Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels
Hamdani, N., Daban, C., Lajnef, M., Gadel, R., Corvoisier, P. L., Delavest, M., Carde, S., Lépine, J., Jamain, S., Houenou, J., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.038 · Cited by 67
Insulin dysfunction and allostatic load in bipolar disorder
Brietzke, E. M., Kapczinski, F. P., Grassi‐Oliveira, R., Grande, I., Vieta, E., & McIntyre, R. S. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.185 · Cited by 64
Self-citation
Interleukin-6 and verbal memory in recurrent major depressive disorder.
Grassi‐Oliveira, R., Bauer, M. E., Pezzi, J. C., Teixeira, A. L., & Brietzke, E. M. (2011) · PubMed · Cited by 64
Self-citation
Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia
Asevedo, E. D. M., Rizzo, L. B., Gadelha, A., Mansur, R. B., Ota, V., Berberian, A. D. A., Scarpato, B. S., Teixeira, A. L., Bressan, R. A., & Brietzke, E. M. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.02.032 · Cited by 63
Self-citation
Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention
Walker, A. J., Kim, Y., Price, J. B., Kale, R. P., McGillivray, J., Berk, M., & Tye, S. J. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00034 · Cited by 68
Evidence for an association between tumor necrosis factor-alpha levels and lithium response
Gülöksüz, S., Altınbaş, K., Çetin, E. A., Kenis, G., Gazioğlu, S. B., Deniz, G., Oral, E., & van Os, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.044 · Cited by 55
Cytokines in schizophrenia: Possible role of anti‐inflammatory medications in clinical and preclinical stages
Mansur, R. B., Zugman, A., Asevedo, E. D. M., da Cunha, G. R., Bressan, R. A., & Brietzke, E. M. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02354.x · Cited by 55
Self-citation
Mechanisms of insulin resistance, mitochondrial dysfunction and the action of the ketogenic diet in bipolar disorder. Focus on the PI3K/AKT/HIF1-a pathway
Campbell, I. H., & Campbell, H. J. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110299 · Cited by 56
Impairments in Peripheral Blood T Effector and T Regulatory Lymphocytes in Bipolar Disorder Are Associated with Staging of Illness and Anti-cytomegalovirus IgG Levels
Maes, M. H. J., Nani, J. V. S., Noto, C. D. S., Rizzo, L. B., Hayashi, M. A. F., & Brietzke, E. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02110-1 · Cited by 54
Self-citation
A theoretical framework informing research about the role of stress in the pathophysiology of bipolar disorder
Brietzke, E. M., Mansur, R. B., Soczynska, J. K., Powell, A. M., & McIntyre, R. S. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.05.004 · Cited by 56
Self-citation
Specific alterations in plasma proteins during depressed, manic, and euthymic states of bipolar disorder
Song, Y., Wu, B. C., Yang, Y., Chen, J., Zhang, L. J., Zhang, Z. W., Shi, H., Huang, C., Pan, J., & Xie, P. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20154550 · Cited by 51
White matter differences in euthymic bipolar I disorder: a combined magnetic resonance imaging and diffusion tensor imaging voxel‐based study
Emsell, L., Langan, C., Hecke, W. V., Barker, G. J., Leemans, A., Sunaert, S. G., McCarthy, P., Nolan, R., Cannon, D. M., & McDonald, C. (2013) · Bipolar Disorders · doi:10.1111/bdi.12073 · Cited by 49
Brain‐derived neurotrophic factor and inflammatory markers in school‐aged children with early trauma
Bücker, J., Fries, G. R., Kapczinski, F. P., Post, R. M., Yatham, L. N., Vianna, P., Chies, J. A. B., Gama, C. S., Magalhães, P. V. D. S., de Aguiar, B. W., et al. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12358 · Cited by 49
Self-citation
Pathophysiology of Bacterial Infection of the Central Nervous System and its Putative Role in the Pathogenesis of Behavioral Changes
Barichello, T., Generoso, J. S., Milioli, G., Galvão-Elias, S., & Teixeira, A. L. (2013) · Brazilian Journal of Psychiatry · doi:10.1016/j.rbp.2012.11.003 · Cited by 49
The Effects of Add-On Low-Dose Memantine on Cytokine Levels in Bipolar II Depression
Lee, S.-Y., Chen, S., Chang, Y.-H., Chen, P. S., Huang, S., Tzeng, N., Wang, Y., Wang, L., Lee, I. H., Wang, T., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000109 · Cited by 46
Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders
Rios, A. C., Maurya, P. K., Pedrini, M., Zeni‐Graiff, M., Asevedo, E. D. M., Mansur, R. B., Wieck, A., Grassi‐Oliveira, R., McIntyre, R. S., Hayashi, M. A. F., et al. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0001 · Cited by 45
Self-citation
Transcriptional and functional effects of lithium in bipolar disorder iPSC-derived cortical spheroids
Osete, J. R., Akkouh, I. A., Ievglevskyi, O., Vandenberghe, M., de Assis, D. R., Ueland, T., Kondratskaya, E., Holen, B., Szabó, A., Hughes, T., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01944-0 · Cited by 52
Serotonin 5- Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases
Nichols, C. D. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/475108 · Cited by 43
Biomarkers and staging of bipolar disorder: a systematic review
Roda, Â., Chendo, I., & Kunz, M. (2014) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2014-0002 · Cited by 43
Bipolar Disorder Associated microRNA, miR-1908-5p, Regulates the Expression of Genes Functioning in Neuronal Glutamatergic Synapses
Kim, Y., Zhang, Y., Pang, K., Kang, H., Park, H., Lee, Y., Lee, B., Lee, H., Kim, W.-K., Geum, D., et al. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.6.296 · Cited by 44
Association of biomarkers and depressive symptoms in schizophrenia
Noto, C. D. S., Gadelha, A., Belangero, S. I., Smith, M. D. A. C., de Aguiar, B. W., Panizzutti, B., Mari, J. D. J., Gama, C. S., Bressan, R. A., & Brietzke, E. M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.10.042 · Cited by 42
Self-citation
Inflammation’s Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder
Lee, S., Chen, S., Chang, Y.-H., Chen, P. S., Huang, S., Tzeng, N., Wang, Y., Wang, L., Lee, I. H., Wang, T.-Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066847 · Cited by 43
Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia
Noto, C. D. S., Gadelha, A., Belangero, S. I., Spíndola, L., Rocha, N. P., de Miranda, A. S., Teixeira, A. L., Smith, M. D. A. C., Mari, J. D. J., Bressan, R. A., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.12.010 · Cited by 41
Self-citation
The Role of TNF‐α and TNF Superfamily Members in the Pathogenesis of Calcific Aortic Valvular Disease
Galeone, A., Paparella, D., Colucci, S. C., Grano, M., & Brunetti, G. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/875363 · Cited by 43
Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy
Hori, H., Yoshimura, R., Katsuki, A., Atake, K., Igata, R., Konishi, Y., & Nakamura, J. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1212172 · Cited by 39
Targeting the Inflammatory Pathway as a Therapeutic Tool for Major Depression
Noto, C. D. S., Rizzo, L. B., Mansur, R. B., McIntyre, R. S., Maes, M. H. J., & Brietzke, E. M. (2014) · NeuroImmunoModulation · doi:10.1159/000356549 · Cited by 39
Self-citation
Bipolar disorder in youth is associated with increased levels of vitamin D-binding protein
Petrov, B., Aldoori, A., James, C. L., Yang, K., Algorta, G. P., Lee, A., Zhang, L., Lin, T., Awadhi, R. A., Parquette, J. R., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0109-7 · Cited by 41
Therapeutic potential of interleukin-6 antagonism in bipolar disorder
Brietzke, E. M., Scheinberg, M. A., & Lafer, B. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.08.021 · Cited by 38
Self-citation
Dysregulation of the NF-κB pathway as a potential inducer of bipolar disorder
Elhaik, E., & Zandi, P. P. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.08.009 · Cited by 38
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
Jung, Y. J., Tweedie, D., Scerba, M. T., Kim, D. S., Palmas, M. F., Pisanu, A., Carta, A. R., & Greig, N. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.656921 · Cited by 37
Serum levels of interleukin-6 and tumor necrosis factor-alpha in exacerbation and remission phase of schizophrenia.
Dunjić-Kostić, B., Jašović‐Gašić, M., Ivković, M., Radonjić, N. V., Pantović-Stefanović, M., Damjanović, A., Poznanović, S. T., Jovanović, A., Nikolić, T., & Petronijević, N. (2013) · PubMed · Cited by 37
Cytomegalovirus Antibody Elevation in Bipolar Disorder: Relation to Elevated Mood States
Prossin, A. R., Yolken, R. H., Kamali, M., Heitzeg, M. M., Kaplow, J. B., Coryell, W. H., & McInnis, M. G. (2015) · Neural Plasticity · doi:10.1155/2015/939780 · Cited by 36
Oxidative markers of Myeloperoxidase and Catalase and their diagnostic performance in bipolar disorder
Selek, S., Altındağ, A., Saraçoğlu, G., & Aksoy, N. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.058 · Cited by 34
Schizophrenia and bipolar disorder: The road from similarities and clinical heterogeneity to neurobiological types
Dacquino, C., Rossi, P. D., & Spalletta, G. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.02.029 · Cited by 38
Early apoptosis in peripheral blood mononuclear cells from patients with bipolar disorder
Fries, G. R., Vasconcelos-Moreno, M. P., Gubert, C., Tietbohl-Santos, B., da Rosa, A. L. S. T., Eisele, B. S., Sartori, J., Pfaffenseller, B., Kapczinski, F. P., & Kauer‐Sant’Anna, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.07.027 · Cited by 34
Self-citation
Glial cells as key elements in the pathophysiology and treatment of bipolar disorder
Keshavarz, M. (2016) · Acta Neuropsychiatrica · doi:10.1017/neu.2016.56 · Cited by 35
Promising link between selenium and peroxisome proliferator activated receptor gamma in the treatment protocols of obesity as well as depression
Donma, M. M., & Donma, O. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.02.008 · Cited by 35
TNF-α and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder
Millett, C. E., Harder, J., Locascio, J. J., Shanahan, M., Santone, G., Fichorova, R. N., Corrigan, A., Baecher‐Allan, C., & Burdick, K. E. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.003 · Cited by 32
Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment
Teixeira, A. L., Souza, R. T. D. A., Zanetti, M. V., Brunoni, A. R., Busatto, G. F., Zarate, C. A., Gattaz, W. F., & Machado‐Vieira, R. (2015) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2450 · Cited by 32
Early life stress and tumor necrosis factor superfamily in crack cocaine withdrawal
Levandowski, M. L., Viola, T. W., Wearick‐Silva, L. E., Wieck, A., Tractenberg, S. G., Brietzke, E. M., Bauer, M. E., Teixeira, A. L., & Grassi‐Oliveira, R. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.02.017 · Cited by 31
Self-citation
The association between systemic lupus erythematosus and bipolar disorder – a big data analysis
Tiosano, S., Nir, Z., Gendelman, O., Comaneshter, D. S., Amital, H., Cohen, A. D., & Amital, D. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.03.006 · Cited by 31
Antimanic-like activity of candesartan in mice: Possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms
Gomes, J. A. D. S., de Souza, G. C., Berk, M., Cavalcante, L. M., de Sousa, F. C. F., Budni, J., de Lucena, D. F., Quevedo, J., Carvalho, A. F., & Macêdo, D. S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.08.005 · Cited by 30
Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms
Cetin, T., Gülöksüz, S., Çetin, E. A., Gazioglu, S. B., Deniz, G., Oral, E., & van Os, J. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-158 · Cited by 30
Reconsidering the Association Between the Major Histocompatibility Complex and Bipolar Disorder
Figueiredo, T. C., & de Oliveira, J. R. M. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9656-6 · Cited by 29
The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia
Turhan, L., Batmaz, S., Koçbıyık, S., & Soygur, A. H. (2016) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1122079 · Cited by 29
ITGB4 deficiency in bronchial epithelial cells directs airway inflammation and bipolar disorder-related behavior
Han, L., Wang, L., Tang, S., Yuan, L., Wu, S., Du, X., Xiang, Y., Qu, X., Liu, H., Luo, H., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1283-5 · Cited by 28
Association of thalamic serotonin transporter and interleukin‐10 in bipolar I disorder: a SPECT study
Hsu, J.-W., Lirng, J., Wang, S., Lin, C.-L., Yang, K., Liao, M., & Chou, Y. H. (2013) · Bipolar Disorders · doi:10.1111/bdi.12164 · Cited by 27
Hidradenitis Suppurativa and Bipolar Disorders: A Population-Based Study
Bitan, D. T., Berzin, D., & Cohen, A. D. (2020) · Dermatology · doi:10.1159/000504535 · Cited by 26
Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database
Thillard, E.-M., Gautier, S., Babykina, E., Carton, L., Amad, A., Bouzillé, G., Beuscart, J., & Chazard, E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00513 · Cited by 26
Is there a role for curcumin in the treatment of bipolar disorder?
Brietzke, E. M., Mansur, R. B., Zugman, A., Carvalho, A. F., Macêdo, D. S., Cha, D. S., Abílio, V. C., & McIntyre, R. S. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.02.001 · Cited by 25
Self-citation
The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder
Hu, L., Kawamoto, E. M., Brietzke, E. M., Scavone, C., & Lafer, B. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.031 · Cited by 24
Self-citation
Osteoprotegerin levels in patients with severe mental disorders
Hope, S., Melle, I. S., Aukrust, P., Agartz, I., Lorentzen, S., Steen, N. E., Djurovic, S., Ueland, T., & Andreassen, O. A. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090088 · Cited by 24
New Pharmacologic Approaches to the Treatment of Bipolar Depression
Keramatian, K., Chakrabarty, T., DuBow, A., Saraf, G., & Yatham, L. N. (2023) · Drugs · doi:10.1007/s40265-023-01872-x · Cited by 21
Glymphatic system dysfunction in mood disorders: Evaluation by diffusion magnetic resonance imaging
Ueda, R., Yamagata, B., Niida, R., Hirano, J., Niida, A., Yamamoto, Y., & Mimura, M. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.07.026 · Cited by 20
Biomarkers and detection methods of bipolar disorder
Hu, X., Yu, C., Dong, T., Yang, Z., Fang, Y., & Jiang, Z. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114842 · Cited by 21
Defective Nitric Oxide–Cyclic Guanosine Monophosphate Signaling in Patients With Bipolar Disorder
Fontoura, P. C., Pinto, V. L. M., Matsuura, C., Resende, Â. C., de Bem, G. F., Ferraz, M. R., Cheniaux, E., Brunini, T. M. C., & Mendes‐Ribeiro, A. C. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182689460 · Cited by 20
Neuroinflammation and Neurotransmission Mechanisms Involved in Neuropsychiatric Disorders
Leite, J. A., Orellana, A. M., Kinoshita, P. F., de Mello, N. P., Scavone, C., & Kawamoto, E. M. (2017) · InTech eBooks · doi:10.5772/intechopen.69343 · Cited by 20
Induction of manic switch by the tumour necrosis factor‐α antagonist infliximab
Elisa, B., & Lafer, B. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02096.x · Cited by 19
Leptin Is Associated with Mood Status and Metabolic Homeostasis in Patients with Bipolar Disorder
Lee, H. J., Kim, S. H., Kim, E. Y., Lee, N. Y., Yu, H. Y., Kim, Y. S., & Ahn, Y. M. (2014) · Neuropsychobiology · doi:10.1159/000366488 · Cited by 18
Effects of eicosapentaenoic acid and docosahexaenoic acid on anxiety-like behavior in socially isolated rats
Oshima, Y., Watanabe, T., Endo, S., Hata, S., Watanabe, T., Osada, K., & Takenaka, A. (2017) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2017.1403888 · Cited by 19
Add‐On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12‐Week Follow‐Up Study
Lee, S.-Y., Wang, T., Chen, S., Chang, Y., Chen, P. S., Huang, S., Tzeng, N., Wang, L., Lee, I. H., Chen, K. C., et al. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13640 · Cited by 17
The immune profile of Major Dysmood Disorder: proof of concept and mechanism using the precision nomothetic psychiatry approachPreprint
Maes, M. H. J., Rachayon, M., Jirakran, K., Sodsai, P., Klinchanhom, S., Gałecki, P., & Sughondhabirom, A. (2022) · medRxiv · doi:10.1101/2022.02.22.22271319 · Cited by 17
Neuroinflammation and excitatory symptoms in bipolar disorder
Sani, G., Panaccione, I., & Spalletta, G. (2015) · Neuroimmunology and Neuroinflammation · doi:10.4103/2347-8659.167304 · Cited by 17
Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats
Barichello, T., Milioli, G., Generoso, J. S., Cipriano, A. L., da Costa, C. S., Moreira, A. P., Vilela, M. C., Comim, C. M., Teixeira, A. L., & Quevedo, J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0749-8 · Cited by 14

Authors: Brietzke, E., & Kapczinski, F.
Affiliations: Universidade Federal do Rio Grande do Sul (BR)
Corresponding author: Kapczinski, Flávio
ORCID: Brietzke, Elisa
Kapczinski, Flávio
Venue: Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publisher: Elsevier BV
Published: 2008-08
Volume: 32
Issue: 6
Pages: 1355-1361
ISSN: 0278-5846 (ISSN-L)
DOI: 10.1016/j.pnpbp.2008.01.006
OpenAlex: W2003038736
Cited by: 163
References: 58
Citations by year: 2026: 3 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 12 · 2021: 1 · 2020: 7 · 2019: 2 · 2018: 7 · 2017: 9 · 2016: 13 · 2015: 15 · 2014: 16 · 2013: 18 · 2012: 8
FWCI: 1.59
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords: TNF-α, bipolar disorder, neuroinflammation, inflammatory cytokines, apoptosis, neuroplasticity, neuronal survival, manic and depressive episodes, serum TNF-α levels, therapeutic target
MeSH terms: Animals, Bipolar Disorder, Cell Survival, Cognition Disorders, Humans, Tumor Necrosis Factor-alpha, Cytokines, NF-kappa B, Apoptosis, Antimanic Agents, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

TNF-α as a molecular target in bipolar disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks